Biological response of cancer cells to radiation treatment

Abstract

Cancer is a class of diseases characterized by uncontrolled cell growth and has the ability to spread or metastasize throughout the body. In recent years, remarkable progress has been made toward the understanding of proposed hallmarks of cancer development, care, and treatment modalities. Radiation therapy or radiotherapy is an important and integral component of cancer management, mostly conferring a survival benefit. Radiation therapy destroys cancer by depositing high-energy radiation on the cancer tissues. Over the years, radiation therapy has been driven by constant technological advances and approximately 50% of all patients with localized malignant tumors are treated with radiation at some point in the course of their disease. In radiation oncology, research and development in the last three decades has led to considerable improvement in our understanding of the differential responses of normal and cancer cells. The biological effectiveness of radiation depends on the linear energy transfer (LET), total dose, number of fractions and radiosensitivity of the targeted cells or tissues. Radiation can either directly or indirectly (by producing free radicals) damages the genome of the cell. This has been challenged in recent years by a newly identified phenomenon known as radiation induced bystander effect (RIBE). In RIBE, the non-irradiated cells adjacent to or located far from the irradiated cells/tissues demonstrate similar responses to that of the directly irradiated cells. Understanding the cancer cell responses during the fractions or after the course of irradiation will lead to improvements in therapeutic efficacy and potentially, benefitting a significant proportion of cancer patients. In this review, the clinical implications of radiation induced direct and bystander effects on the cancer cell are discussed.

Research and Development of Radioprotective Agents: A Mini-Review

“…Although it is believed over a century that cancer cells were more radiosensitive compared to the normal cells, to completely eliminate the cancer cells, higher doses must be delivered to the tumor. This leads to more toxic effect on the surrounding normal tissues [66] that could affect a patient's quality of life. Consequently, this will bring radiation dose reductions or treatment delays that can lead to poor therapeutic outcome [67] .…”

Radiation‐Sensitive Dendrimer‐Based Drug Delivery System

“…Radiation affects cells directly by damaging DNA and indirectly by exciting water molecules and producing free radicals. Exposure to γ‐radiation mediates the lysis of water, generating reactive oxygen species (ROS) and causing functional deficiency and apoptosis of cells 2, 3, 4. In certain tumors, cancer cell survival rates after radiotherapy are high (e.g., early‐stage laryngeal cancer and nonsmall cell lung cancer) 5.…”

Role of adenosine in tumor progression: focus on A2B receptor as potential therapeutic target

“…[3] Radiotherapy is another important treatment currently used for several tumors, through which cancer cells are either directly killed upon DNA damage by depositing high physical energy of radiation, or indirectly due to the release of free radicals. [4] Nowadays the most novel anti-cancer strategies are the targeted-therapy and immunotherapy. The cancer targeted-therapy uses small molecules that can block fundamental pathways or mutant proteins essential for tumor growth.…”